JUL 27, 2016 8:30 AM PDT

Could lupus treatment spare immune system?

Image Credit: iStockphoto

A new discovery could one day improve treatments for lupus sufferers, saving thousands of people each year from serious illness or death caused by secondary infections.

Lupus is a vicious and widespread autoimmune disease that can attack any part of the body. It affects 5 million people worldwide, and its victims are typically young women. Indigenous and Asian people suffer higher rates than other groups.

Current treatments for lupus essentially “switch off” the patient’s immune system to stop it from attacking their body, according to lead researcher Will Figgett of Monash University’s immunology department.

This leaves patients vulnerable to any passing infection, and given that they are often in the hospital due to the severity of lupus, the risk of exposure to another disease is high.

Stop lupus, keep immune system

Figgett and colleagues, working with Professor Fabienne Mackay of the immunology department, have found a way to stop lupus without stopping the immune system by focusing on a specific receptor found on B cells—the “soldiers” of the immune system.

In healthy people, B cells attack diseases by producing antibodies that destroy invading pathogens. In lupus sufferers, B cells are misdirected to produce autoantibodies—cells that destroy the patient’s own healthy tissue.

Most commonly, lupus affects the skin and joints, but it can also strike the brain, kidneys, and almost anywhere in the body.

In order to survive, B cells rely on a particular protein—called B cell Activating Factor of the TNF Family (BAFF), however too much BAFF causes lupus to develop. Each B cell carries three different kinds of receptor that detect BAFF in the blood stream. The receptors are known as BAFF-R, BCMA, and TACI. It is the TACI receptor that responds to excesses of BAFF, becoming overstimulated and triggering production of even stronger autoantibodies to attack healthy tissue.

Intact B cells

The researchers find that if the TACI receptor is deleted, the B cells remain intact but lupus doesn’t develop no matter how much BAFF is in the blood.

Figgett says that while B cells are vital to a healthy immune system, the TACI receptor itself is not crucial—the cell can fight most diseases without it.

“Among current lupus drugs, the most recent advancement is belimumab, which was thought to work by ‘mopping up’ the large amounts of extra BAFF in the patients and limiting the production of new B cells while under treatment,” he says.

“This does help, but patients are left defenseless against a host of other illnesses. We have discovered that where the TACI receptor had been deleted from the genome, high BAFF levels don’t get lupus even though they should.

The first step to make a new medicine is to find a suitable target. This is a better way to try and cure lupus because most of the natural immune system will remain intact to protect the patient,” says Figgett.

Source: Monash University

This article was originally published on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
FEB 23, 2020
FEB 23, 2020
New discovery could help preterm babies breathe easy
Babies born more than three weeks before full term are met with complicated and often life-threatening health challenges ...
APR 08, 2020
Drug Discovery & Development
APR 08, 2020
Does Tuberculosis Vaccine Really Defend from COVID-19?
The spread of COVID-19 has panned out very differently in different countries. While in some such as the US, the UK and ...
APR 16, 2020
APR 16, 2020
The Unseen Barriers Surrounding Pancreatic Cancer
Pancreatic cancer is one of the deadliest cancers in the world. With a poor five year prognosis and lack of effective tr ...
APR 20, 2020
APR 20, 2020
Making Sense of the T Cell Response Spectrum
T cells go through a sort of “training” process throughout life, and scientists recently discovered that the ...
APR 22, 2020
Drug Discovery & Development
APR 22, 2020
Only 3% of COVID-19 Antibody Tests Approved by FDA
So far, only 3% of at least 90 COVID-19 antibody tests in the US have been approved by the Food and Drug Administration ...
MAY 07, 2020
Cell & Molecular Biology
MAY 07, 2020
How the Function of a Critical Immune Cell is Related to Metabolism
This work suggests that it may be possible to dampen autoimmunity or promote an immune attack on cancer through a bioche ...
Loading Comments...